The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia.

Blood Advances
Lauren M BrownPaul G Ekert

Abstract

Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, and implementation of risk-adapted therapy has been instrumental in the dramatic improvements in clinical outcomes. A key to risk-adapted therapies includes the identification of genomic features of individual tumors, including chromosome number (for hyper- and hypodiploidy) and gene fusions, notably ETV6-RUNX1, TCF3-PBX1, and BCR-ABL1 in B-cell ALL (B-ALL). RNA-sequencing (RNA-seq) of large ALL cohorts has expanded the number of recurrent gene fusions recognized as drivers in ALL, and identification of these new entities will contribute to refining ALL risk stratification. We used RNA-seq on 126 ALL patients from our clinical service to test the utility of including RNA-seq in standard-of-care diagnostic pipelines to detect gene rearrangements and IKZF1 deletions. RNA-seq identified 86% of rearrangements detected by standard-of-care diagnostics. KMT2A (MLL) rearrangements, although usually identified, were the most commonly missed by RNA-seq as a result of low expression. RNA-seq identified rearrangements that were not detected by standard-of-care testing in 9 patients. These were found in patients who were not classifiable using standard molecular ass...Continue Reading

References

Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M SmithR Ungerleider
Sep 27, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John M GoldbergBarbara L Asselin
Mar 9, 2007·Nature·Charles G MullighanJames R Downing
Jan 9, 2009·The New England Journal of Medicine·Charles G MullighanUNKNOWN Children's Oncology Group
Jan 17, 2009·The Lancet Oncology·Elaine Coustan-SmithDario Campana
May 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Charles G MullighanCheryl L Willman
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen P HungerWilliam L Carroll
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony V MoormanChristine J Harrison
Feb 4, 2014·CA: a Cancer Journal for Clinicians·Elizabeth WardAhmedin Jemal
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn G RobertsChing-Hon Pui
Sep 11, 2014·The New England Journal of Medicine·Kathryn G RobertsCharles G Mullighan
Jan 18, 2015·Oncotarget·Martin NeumannClaudia D Baldus
Mar 18, 2015·Nature Reviews. Clinical Oncology·Kathryn G Roberts, Charles G Mullighan
May 29, 2015·Genome Medicine·Nadia M DavidsonAlicia Oshlack
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rob PietersJacques Van Dongen
Nov 1, 2016·Nature Genetics·Jinghui ZhangUNKNOWN St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
Mar 7, 2017·Nature Methods·Rob PatroCarl Kingsford
Jul 10, 2018·GigaScience·Breon M SchmidtAlicia Oshlack
Oct 23, 2018·The Journal of Molecular Diagnostics : JMD·Borahm KimJong Rak Choi
Nov 30, 2018·Proceedings of the National Academy of Sciences of the United States of America·Jian-Feng LiJin-Yan Huang
Jan 16, 2019·Nature Genetics·Zhaohui GuCharles G Mullighan

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.